Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2005 3
2006 3
2007 1
2008 1
2012 3
2013 2
2014 5
2015 7
2016 3
2017 3
2018 1
2019 1
2020 2
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
First Extensive Analysis of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic Tumor Volume Affects Prognosis.
Louarn N, Galicier L, Bertinchamp R, Lussato D, Montravers F, Oksenhendler É, Merlet P, Gérard L, Vercellino L. Louarn N, et al. Among authors: merlet p. J Clin Oncol. 2022 Apr 20;40(12):1346-1355. doi: 10.1200/JCO.21.01228. Epub 2022 Jan 24. J Clin Oncol. 2022. PMID: 35073166
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.
Vercellino L, Di Blasi R, Kanoun S, Tessoulin B, Rossi C, D'Aveni-Piney M, Obéric L, Bodet-Milin C, Bories P, Olivier P, Lafon I, Berriolo-Riedinger A, Galli E, Bernard S, Rubio MT, Bossard C, Meignin V, Merlet P, Feugier P, Le Gouill S, Ysebaert L, Casasnovas O, Meignan M, Chevret S, Thieblemont C. Vercellino L, et al. Among authors: merlet p. Blood Adv. 2020 Nov 24;4(22):5607-5615. doi: 10.1182/bloodadvances.2020003001. Blood Adv. 2020. PMID: 33180899 Free PMC article.
Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma.
Reger de Moura C, Vercellino L, Jouenne F, Baroudjian B, Sadoux A, Louveau B, Delyon J, Serror K, Goldwirt L, Merlet P, Bouquet F, Battistella M, Lebbé C, Mourah S. Reger de Moura C, et al. Among authors: merlet p. Transl Oncol. 2020 Feb;13(2):275-286. doi: 10.1016/j.tranon.2019.10.003. Epub 2019 Dec 23. Transl Oncol. 2020. PMID: 31874374 Free PMC article.
18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients.
de Cremoux P, Biard L, Poirot B, Bertheau P, Teixeira L, Lehmann-Che J, Bouhidel FA, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, Groheux D. de Cremoux P, et al. Among authors: merlet p. Oncotarget. 2018 Mar 27;9(23):16343-16353. doi: 10.18632/oncotarget.24674. eCollection 2018 Mar 27. Oncotarget. 2018. PMID: 29662649 Free PMC article.
Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.
Lemarignier C, Martineau A, Teixeira L, Vercellino L, Espié M, Merlet P, Groheux D. Lemarignier C, et al. Among authors: merlet p. Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1145-1154. doi: 10.1007/s00259-017-3641-4. Epub 2017 Feb 10. Eur J Nucl Med Mol Imaging. 2017. PMID: 28188325 Clinical Trial.
39 results